-
Je něco špatně v tomto záznamu ?
Decreased level of endogenous secretory receptor for advanced glycation end-products in diabetes with concomitant hyperlipidemia
Z. Turk, S. Ljubić, J. Boras
Jazyk angličtina Země Česko
Typ dokumentu časopisecké články, práce podpořená grantem
NLK
Directory of Open Access Journals
od 1991
Free Medical Journals
od 1998
ProQuest Central
od 2005-01-01
Medline Complete (EBSCOhost)
od 2006-01-01
Nursing & Allied Health Database (ProQuest)
od 2005-01-01
Health & Medicine (ProQuest)
od 2005-01-01
ROAD: Directory of Open Access Scholarly Resources
od 1998
- MeSH
- biologické markery krev MeSH
- diabetes mellitus 2. typu krev diagnóza epidemiologie MeSH
- dospělí MeSH
- hyperlipidemie krev epidemiologie MeSH
- lidé středního věku MeSH
- lidé MeSH
- produkty pokročilé glykace krev MeSH
- receptory imunologické krev MeSH
- senioři MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
Endogenous secretory receptor (esRAGE) for advanced glycation end-product (AGE) acts as decoy for AGEs. The AGE-to-esRAGE ratio was hypothesized to be implicated in diabetic vasculopathy. We investigated an association of esRAGE and methylglyoxal-adducts serum level, as well as AGE-to-esRAGE ratio in subpopulation of diabetic patients with or without concomitant hyperlipidemia and macrovascular disease in history. In diabetes with concomitant hyperlipidemia esRAGE was significantly decreased compared to hyperlipidemia with normal glucose metabolism (0.306+/-0.2 vs. 0.367+/-0.1; p=0.019) or diabetes alone (0.306+/-0.2 vs. 0.404+/-0.1; p=0.004). High AGE/esRAGE ratio, found in diabetic patients with hyperlipidemia, pointed to increased production of AGEs and low expression of esRAGE. In multivariable analysis adjusted for several confounding factors, increased AGE/esRAGE ratio was recognized as a high risk for vascular disease outcomes.
Department of Laboratory Medicine Vuk Vrhovac Clinic KB Merkur Zagreb Croatia
Department of Medicine Vuk Vrhovac Clinic KB Merkur Zagreb Croatia
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc15003897
- 003
- CZ-PrNML
- 005
- 20150129121314.0
- 007
- ta
- 008
- 150128s2014 xr d f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.33549/physiolres.932559 $2 doi
- 035 __
- $a (PubMed)24397807
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Turk, Z $u Department of Laboratory Medicine, Vuk Vrhovac Clinic, KB Merkur, Zagreb, Croatia
- 245 10
- $a Decreased level of endogenous secretory receptor for advanced glycation end-products in diabetes with concomitant hyperlipidemia / $c Z. Turk, S. Ljubić, J. Boras
- 520 9_
- $a Endogenous secretory receptor (esRAGE) for advanced glycation end-product (AGE) acts as decoy for AGEs. The AGE-to-esRAGE ratio was hypothesized to be implicated in diabetic vasculopathy. We investigated an association of esRAGE and methylglyoxal-adducts serum level, as well as AGE-to-esRAGE ratio in subpopulation of diabetic patients with or without concomitant hyperlipidemia and macrovascular disease in history. In diabetes with concomitant hyperlipidemia esRAGE was significantly decreased compared to hyperlipidemia with normal glucose metabolism (0.306+/-0.2 vs. 0.367+/-0.1; p=0.019) or diabetes alone (0.306+/-0.2 vs. 0.404+/-0.1; p=0.004). High AGE/esRAGE ratio, found in diabetic patients with hyperlipidemia, pointed to increased production of AGEs and low expression of esRAGE. In multivariable analysis adjusted for several confounding factors, increased AGE/esRAGE ratio was recognized as a high risk for vascular disease outcomes.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a biologické markery $x krev $7 D015415
- 650 _2
- $a diabetes mellitus 2. typu $x krev $x diagnóza $x epidemiologie $7 D003924
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a produkty pokročilé glykace $x krev $7 D017127
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a hyperlipidemie $x krev $x epidemiologie $7 D006949
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a receptory imunologické $x krev $7 D011971
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Ljubić, S $u Department of Medicine, Vuk Vrhovac Clinic, KB Merkur, Zagreb, Croatia
- 700 1_
- $a Boras, J $u Department of Medicine, Vuk Vrhovac Clinic, KB Merkur, Zagreb, Croatia
- 773 0_
- $w MED00003824 $t Physiological research $x 1802-9973 $g Roč. 63, č. 2 (2014), s. 199-205
- 856 41
- $u http://www.biomed.cas.cz/physiolres/ $y domovská stránka časopisu
- 910 __
- $a ABA008 $b A 4120 $c 266 $y 4 $z 0
- 990 __
- $a 20150128 $b ABA008
- 991 __
- $a 20150129121509 $b ABA008
- 999 __
- $a ok $b bmc $g 1060957 $s 886652
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2014 $b 63 $c 2 $d 199-205 $i 1802-9973 $m Physiological research $n Physiol. Res. (Print) $x MED00003824
- LZP __
- $b NLK118 $a Pubmed-20150128